Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

How Much of a Bargain Is Johnson & Johnson Stock Right Now?
Motley Fool
Sunday, September 12, 2010 - 11:24am
tags:
JNJ, investors
Court Denies Class-Action Status in Lilly Drug Case
NY Times
Sunday, September 12, 2010 - 11:23am
tags:
Eli Lilly, Zyprexa, legal
ZYBRESTAT(TM) (CA4P) Improves Overall Survival in a Phase 2/3 Trial (FACT Study) of Patients With Anaplastic Thyroid Cancer (ATC)
Yahoo/Globe NewsWire
Sunday, September 12, 2010 - 11:22am
tags:
Zybrestat, Oxigene, thyroid cancer
Small Cap Biotech Stocks: 7 Picks, 1 Big Concern
Seeking Alpha
Sunday, September 12, 2010 - 11:20am
tags:
Chelsea Therapeutics, Clinical Data, Savient, DUSA pharmaceuticals, Neurologix, Lpath
Idenix Hopes to Resume Course With Hepatitis C Drugs by Year's End
Seeking Alpha
Sunday, September 12, 2010 - 11:17am
tags:
Idenix, hepatitis C, Bristol-Myers Squibb, ZymoGenetics, Vertex Pharmaceuticals, Telaprevir, Regulus, GSK, Merck
U.S. Attorney General: Misuse of prescription painkillers a serious problem
Barre Montpelier Times Argus, VT
Saturday, September 11, 2010 - 2:58pm
tags:
opiates, pain management
RXi Pharmaceuticals in line for partnership/investment deal with Big Pharma. Again?
Smallcap Network
Saturday, September 11, 2010 - 2:56pm
tags:
RXi Pharmaceuticals
FDA gives green light to KV drug manufacturing
St. Louis Post-Dispatch, MO
Saturday, September 11, 2010 - 2:54pm
tags:
KV Pharmaceutical
Kahn Swick & Foti, LLC and Former Louisiana Attorney General Notify XenoPort Shareholders With Large Financial Interests of Securities Fraud Class Action
Yahoo/Businesswire
Saturday, September 11, 2010 - 12:24pm
tags:
XenoPort, legal
Genome Sequencing Going Down Market
Investor's Business Daily
Saturday, September 11, 2010 - 11:39am
tags:
genome sequencing, Illumina
MannKind Evenly Poised
Yahoo/Zacks
Saturday, September 11, 2010 - 11:37am
tags:
MannKind, investors
Hana Biosciences Reverse Stock Split Effective Monday, September 13, 2010
Yahoo/Globe NewsWire
Saturday, September 11, 2010 - 11:36am
tags:
Hana Biosciences, investors
Bristol-Myers Pays A Premium For Its Partner
Investopedia
Saturday, September 11, 2010 - 11:35am
tags:
Bristol-Myers Squibb, ZymoGenetics, Merck Serono, Novo Nordisk
How Expensive Is Abbott Laboratories Stock Right Now?
Motley Fool
Saturday, September 11, 2010 - 11:33am
tags:
Abbott Laboratories, investors
U.S. Court of Appeals Reverses Third-Party Payor Class Certification Suit Against Lilly
Yahoo/PR NewsWire
Saturday, September 11, 2010 - 11:32am
tags:
Eli Lilly, legal
Brain Cancer Drug Appeal Could Impact Merck, Teva
Seeking Alpha
Saturday, September 11, 2010 - 11:30am
tags:
Merck, Teva Pharmaceuticals, brain cancer, Temodar
FDA Approves New Dosing for FASLODEX® (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
Yahoo/PR NewsWire
Saturday, September 11, 2010 - 11:28am
tags:
Faslodex, .breast cancer, AstraZeneca
Genzyme to cut 8% of global workforce: reports
Marketwatch
Friday, September 10, 2010 - 6:15pm
tags:
layoffs, Genzyme, Sanofi, M&A
Four Biotech Takeout Candidates
Forbes
Friday, September 10, 2010 - 11:57am
tags:
biotech, ViroPharma, Geron, Pharmacyclics, Allos, M&A
J&J unblinds cancer drug study on effectiveness
Yahoo/AP
Friday, September 10, 2010 - 11:55am
tags:
prostate cancer, JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.